Carregant...
Efficacy of Brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients
BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) recipients are at risk for herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. Routine prophylaxis with acyclovir is recommended during periods of immunosuppression. Brincidofovir (BCV, CMX001), a lipid conjugate of cidof...
Guardat en:
| Publicat a: | Transpl Infect Dis |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310478/ https://ncbi.nlm.nih.gov/pubmed/30120866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12977 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|